Europe Enzyme Replacement Therapy Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Enzyme Replacement Therapy Market – By Enzyme Type

1.3.2 Europe Enzyme Replacement Therapy Market – By Therapeutic Conditions

1.3.3 Europe Enzyme Replacement Therapy Market – By Route of Administration

1.3.4 Europe Enzyme Replacement Therapy Market – By End User

1.3.5 Europe Enzyme Replacement Therapy Market – By Country

2. Europe Enzyme Replacement Therapy Market– Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Enzyme Replacement Therapy Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe – PEST Analysis

4.3 Expert Opinion

5. Europe Enzyme Replacement Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Lysosomal Storage Diseases (LSDs)

5.1.2 Rapid Regulatory Approval with Other Benefits for Drug with Orphan Drug Designation

5.2 Market Restraints

5.2.1 Cutthroat Competition among Market Players

5.3 Market Opportunities

5.3.1 Increasing Partnerships and Collaborations to Synergize the Business

5.4 Future Trends

5.4.1 Innovative Developments in ERT

5.5 Impact Analysis

6. Enzyme Replacement Therapy Market– Europe Analysis

6.1 Europe Enzyme Replacement Therapy Market Revenue Forecast and Analysis

7. Europe Enzyme Replacement Therapy Market Revenue and Forecasts To 2028– by Enzyme Type

7.1 Overview

7.2 Europe Enzyme Replacement Therapy Market, By Enzyme Type 2021 & 2028 (%)

7.3 Alglucosidase Alfa

7.3.1 Overview

7.3.2 Alglucosidase Alfa Revenue and Forecast to 2028 (US$ Million)

7.4 Agalsidase Beta

7.4.1 Overview

7.4.2 Agalsidase Beta - Revenue and Forecast to 2028 (US$ Million)

7.5 Imiglucerase

7.5.1 Overview

7.5.2 Imigluceras - Revenue and Forecast to 2028 (US$ Million)

7.6 Idursulfase

7.6.1 Overview

7.6.2 Idursulfase - Revenue and Forecast to 2028 (US$ Million)

7.7 Galsulfase

7.7.1 Overview

7.7.2 Galsulfase - Revenue and Forecast to 2028 (US$ Million)

7.8 Velaglucerase Alfa

7.8.1 Overview

7.8.2 Velaglucerase Alfa - Revenue and Forecast to 2028 (US$ Million)

7.9 Other Enzymes

7.9.1 Overview

7.9.2 Other Enzymes - Revenue and Forecast to 2028 (US$ Million)

8. Europe Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Therapeutic Conditions

8.1 Overview

8.2 Europe Enzyme Replacement Therapy Market, By Therapeutic Conditions 2021 & 2028 (%)

8.3 Gaucher's Disease

8.3.1 Overview

8.3.2 Gaucher's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.4 Fabry's Disease

8.4.1 Overview

8.4.2 Fabry's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.5 Mucopolysaccharidosis (MPS)

8.5.1 Overview

8.5.2 MPS - Market Revenue and Forecast to 2028 (US$ Million)

8.6 Pompe's Disease

8.6.1 Overview

8.6.2 Pompe's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.7 SCID

8.7.1 Overview

8.7.2 SCID - Market Revenue and Forecast to 2028 (US$ Million)

8.8 Other Therapeutic Conditions

8.8.1 Overview

8.8.2 Other Therapeutic Conditions - Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Route of Administration

9.1 Overview

9.2 Europe Enzyme Replacement Therapy Market, By Route of Administration 2021 & 2028 (%)

9.3 Parenteral

9.3.1 Overview

9.3.2 Parenteral - Market Revenue and Forecast to 2028 (US$ Million)

9.4 Oral

9.4.1 Overview

9.4.2 Oral - Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Enzyme Replacement Therapy Market Analysis– By End User

10.1 Overview

10.2 Europe Enzyme Replacement Therapy Market, By End User 2021 & 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)

10.4 Infusion Centers

10.4.1 Overview

10.4.2 Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others - Market Revenue and Forecasts To 2028 (US$ Million)

11. Europe Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 – Country Analysis

11.1 Europe: Enzyme Replacement Therapy Market

11.1.1 Overview

11.1.3 Europe: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)

11.1.3.1 Germany: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.1.1 Overview

11.1.3.1.2 Germany: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.1.3 Germany: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.1.4 Germany: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.1.5 Germany: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.1.6 Germany: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

11.1.3.2 UK: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.2.1 Overview

11.1.3.2.2 UK: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.2.3 UK: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.2.4 UK: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.2.5 UK: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.2.6 UK: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

11.1.3.3 France: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.3.1 Overview

11.1.3.3.2 France: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.3.3 France: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.3.4 France: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.3.5 France: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.3.6 France: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

11.1.3.4 Italy: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.4.1 Overview

11.1.3.4.2 Italy: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.4.3 Italy: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.4.4 Italy: Enzyme Replacem4ent Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.4.5 Italy: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.4.6 Italy: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

11.1.3.5 Spain: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.5.1 Overview

11.1.3.5.2 Spain: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.5.3 Spain: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.5.4 Spain: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.5.5 Spain: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.5.6 Spain: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

11.1.3.6 Rest of Europe: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.6.1 Overview

11.1.3.6.2 Rest of Europe: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.6.3 Rest of Europe: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.6.4 Rest of Europe: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.6.5 Rest of Europe: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.6.6 Rest of Europe: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

12. Europe Enzyme Replacement Therapy Market–Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Sanofi

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 BioMarin Pharmaceutical Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Takeda Pharmaceutical Company Limited

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 AbbVie Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Alexion Pharmaceuticals, Inc. (AstraZeneca)

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 WOT Analysis

13.6.6 Key Developments

13.7 Amicus Therapeutics

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Recordati S.p.A.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 CHIESI Farmaceutici S.p.A.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Pfizer Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 2. Germany Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4. Germany Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. UK Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 6. UK Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 7. UK Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 8. UK Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. France Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. France Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 11. France Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 12. France Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Italy Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. Italy Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 15. Italy Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 16. Italy Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Spain Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. Spain Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 19. Spain Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 20. Spain Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Europe Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Europe Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Europe Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25. Recent Inorganic Growth Strategies in the Enzyme Replacement Therapy Market

Table 26. Recent Organic Growth Strategies in the Enzyme Replacement Therapy Market

Table 27. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Enzyme Replacement Therapy Market Segmentation

Figure 2. Europe Enzyme Replacement Therapy Market Segmentation, By Country

Figure 3. Europe Enzyme Replacement Therapy Market Overview

Figure 4. Europe Enzyme Replacement Therapy Market, By Enzyme Type

Figure 5. Europe Enzyme Replacement Therapy Market, By Country

Figure 7. Europe: PEST Analysis

Figure 8. Expert Opinion

Figure 9. Europe Impact Analysis

Figure 10. Europe Enzyme Replacement Therapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 11. Europe Enzyme Replacement Therapy Market, by Enzyme Type 2021 & 2028 (%)

Figure 12. Europe Alglucosidase Alfa Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Europe Agalsidase Beta - Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Europe Imiglucerase - Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Europe Idursulfase - Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Europe Galsulfase - Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Europe Velaglucerase Alfa - Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Europe Other Enzymes - Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Europe Enzyme Replacement Therapy Market, by Therapeutic Conditions 2021 & 2028 (%)

Figure 20. Europe Gaucher's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Europe Fabry's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Europe MPS - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Europe Pompe's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Europe SCID - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Europe Other Therapeutic Conditions - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Europe Enzyme Replacement Therapy Market, by Route of Administration 2021 & 2028 (%)

Figure 27. Europe Parenteral - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Europe Oral - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Europe Enzyme Replacement Therapy Market, by End User 2021 & 2028 (%)

Figure 30. Europe Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. Europe Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32. Europe Others- Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33. Europe: Enzyme Replacement Therapy Market, by Key Country – Revenue (2021) (US$ Million)

Figure 34. Europe: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)

Figure 35. Germany: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. UK: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. France: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Italy: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Spain: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Rest of Europe: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)